Galen Robotics Announces Over-Subscribed $15 Million Series A To Advance Next Phase in Surgical Robotics
Galen Robotics Announces Over-Subscribed $15 Million Series A To Advance Next Phase in Surgical Robotics: Digital-Surgery-as-a-Service
Baltimore startup raises $3.5M as it prepares to seek FDA approval for new pneumonia test
Baltimore startup raises $3.5M as it prepares to seek FDA approval for new pneumonia test Email Facebook LinkedIn Twitter Share article
Pearl Diagnostics, led by founder Kieren Marr, raised a $3.5 million seed round.
Courtesy of Pearl Diagnostics
By Matt Hooke – Reporter
July 18, 2022, 07:13am EDT
A Baltimore medical company that aims to make it easier to diagnose a deadly type of pneumonia raised $3.5 million in an oversubscribed seed round.
Pearl Diagnostics, led by Johns Hopkins University Professor Kieren Marr, plans to use the funding to focus on manufacturing, in preparation for the commercial launch of its urine antigen test for fungal pneumonia. The test is already approved for sale in Europe and the company is currently seeking approval in the United States as well. Pearl plans on submitting its test for FDA approval at the end of this year.
Pearl Diagnostics previously earned around $5 million from the Maryland Technology Development Corp. (TEDCO), the National Science Foundation, the National Institutes of Health and the Cystic Fibrosis Foundation. The company, originally called Mycomed Technologies, has been headquartered at the FastForward U incubator at Johns Hopkins University. The company originally sought to raise $2.5-$3 million. The round closed…
Baltimore Medtech Sector a Key Asset for Ascending Biotech Cluster, Part Two
This is Part Two of our series on the vibrant Baltimore medtech ecosystem gaining significant momentum in Baltimore. Part One featured five exciting companies, including CoapTech, JuneBrain, ClearMask, LifeSprout, and NextStep Robotics.
Life Science Development Projects Position Baltimore BioMed Ecosystem for Boom
The Baltimore biotech ecosystem is thriving. And new, big and bold life sciences development projects are in the works, leading many to project Charm City as the next sector of the BioHealth Capital Region (BHCR) to boom.
Medical device companies find an ideal home in the UM BioPark
In 2003, a group of University of Maryland officials approached then-mayor Martin O’Malley with a development plan for vacant land along West Baltimore Street, adjacent to University of Maryland, Baltimore’s campus. Today, this ambitious project, the University of Maryland BioPark, boasts nearly three dozen life science companies, ranging from leading global firms to mature companies to early-stage ventures.
In recent years, the BioPark has attracted a cluster of early-stage medical device companies. For these young companies, the BioPark offers something even more important than a corporate headquarters: a location on UMB’s campus and in the heart of Maryland’s biomed ecosystem.
“The real magnet to coming to our research park is the University of Maryland, Baltimore,” said UM BioPark Executive Director Jane Shaab. “As a leading academic medical center, the quality and scope of research going on here is what companies want to access.”
BTI Awarded Workforce Grant to Train 40 Lab Workers in Baltimore City
Baltimore Mayor Brandon Scott announced that BTI will is one of 17 recipients of new grants totaling nearly $5 million via the American Rescure Plan Act to train under- and unemployed Baltimore City residents.
CoapTech Announces IDE Approval from FDA to Initiate Clinical Trial for its PUMA-G Peds System for Pediatric Gastrostomy
CoapTech, Inc, a medical device company focused on delivering transformative solutions for minimally-invasive surgery, announced today it has received an Investigational Device Exemption (IDE) approval from the Food and Drug Administration (FDA) to initiate a clinical trial for its PUMA-G Peds System, a device designed to provide a safer and more efficient way to place feeding tubes in children.
Three Local Biotechs Focused on Improving Military Performance and Medical Care
Biotech companies focused on developing biodefense products and measures are well known throughout the BioHealth Capital Region (BHCR). Companies like BioFactura, which is developing a smallpox therapeutic, and Emergent BioSolutions, which is advancing an anthrax vaccine, are two regional organizations BioBuzz has covered extensively.
Ezekiel Kelley Joins Workforce Genetics as Director of Operations and Workforce Development Solutions
Workforce Genetics welcomes Ezekiel Kelley as the new Director of Operations and Workforce Development Solutions. Ezekiel will establish and implement efficient operating systems to drive growth across the whole organization – including the Recruiting and BioBuzz divisions. Additionally, he will be the head architect for building innovative new workforce solutions; including a new online community and talent marketplace that seeks to expand access to virtual workforce development and education tools, increase career mobility, and democratize access to rewarding life science careers.
Maryland Real Estate Roundup 2021
This year, Maryland continued to prove why it’s becoming one of the strongest biohealth clusters in the country. The state’s commitment to businesses in the life science, pharmaceutical, and biotech industries has continued as both the private and public sectors work to meet the demand for more space. Here are a few of the biggest real estate projects in Maryland in 2021. Some of these projects are still under construction, while others were unveiled this year.